SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
2.400
+0.090 (3.90%)
Feb 13, 2026, 4:00 PM EST - Market closed
SeaStar Medical Holding Employees
SeaStar Medical Holding had 19 employees as of December 31, 2024. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$46,368
Profits / Employee
-$719,211
Market Cap
8.65M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 19 | 7 | 58.33% |
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Sep 30, 2022 | 8 | 5 | 166.67% |
| Jun 30, 2022 | 3 | - | - |
| Mar 31, 2022 | 3 | - | - |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 117 |
| Bolt Biotherapeutics | 40 |
| NuCana | 22 |
| Edesa Biotech | 17 |
| CalciMedica | 15 |
| BioVie | 13 |
| XTL Biopharmaceuticals | 10 |
| TransCode Therapeutics | 7 |
ICU News
- 5 days ago - SeaStar Medical Announces Publication in Pediatric Nephrology of Positive Real-World Experience for QUELIMMUNE™ (SCD-PED) Therapy in Pediatric Acute Kidney Injury (AKI) - GlobeNewsWire
- 16 days ago - SeaStar Medical to Present at Upcoming Noble Capital Markets Emerging Growth Virtual Equity Conference - GlobeNewsWire
- 5 weeks ago - SeaStar Medical Announces 2026 Milestones - GlobeNewsWire
- 5 weeks ago - SeaStar Medical to Present at Upcoming Biotech Showcase 2026 Investor Conference - GlobeNewsWire
- 7 weeks ago - SeaStar Medical Announces 1-for-10 Reverse Split - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - GlobeNewsWire
- 3 months ago - SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - GlobeNewsWire
- 3 months ago - SeaStar Medical Announces Appointment of Michael Messinger as CFO - GlobeNewsWire